http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2016375007-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a693232b92910547c898db10feb83fef
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-485
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-20
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-485
filingDate 2016-04-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d80f96d7bd07d1191df60b3cc6e2d741
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ed882562fe4960724b5dc41e0ca20097
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f92c43b8b9083581b19e418e5ae0ace0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3d1bc28e4d3004161c391b6f396388ae
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_06f136e07d7b42cc49adf695ab8fdd60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1b4d9132875eac2df6a902ac02201b00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dc750986409a15a78d73de0ac0346af1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3fae14e4ec33cab2357638d07277521c
publicationDate 2016-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2016375007-A1
titleOfInvention Nalmefene for Reduction of Alcohol Consumption in Specific Target Populations
abstract The present invention relates to nalmefene for use in the reduction of alcohol consumption in a patient with alcohol dependence who has a high drinking risk level. The present invention also relates to nalmefene for use in the reduction of alcohol consumption in a patient with alcohol dependence who maintains a high DRL after an observation period following initial assessment.
priorityDate 2012-06-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419501490
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID134664
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5497189
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393830
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399399
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5284594
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11177
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5360515
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226421102
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393829
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226504157
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID45051774
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226421524

Total number of triples: 38.